Tactile Systems Technology, Inc. (TCMD)
- Previous Close
14.14 - Open
14.10 - Bid 14.35 x 100
- Ask 14.44 x 100
- Day's Range
14.10 - 14.63 - 52 Week Range
9.69 - 26.11 - Volume
156,044 - Avg. Volume
295,293 - Market Cap (intraday)
342.137M - Beta (5Y Monthly) 1.21
- PE Ratio (TTM)
11.71 - EPS (TTM)
1.23 - Earnings Date May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
20.67
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
tactilemedical.comRecent News: TCMD
Performance Overview: TCMD
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TCMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TCMD
Valuation Measures
Market Cap
342.02M
Enterprise Value
317.16M
Trailing P/E
11.70
Forward P/E
25.25
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.22
Price/Book (mrq)
1.77
Enterprise Value/Revenue
1.16
Enterprise Value/EBITDA
12.92
Financial Highlights
Profitability and Income Statement
Profit Margin
10.39%
Return on Assets (ttm)
3.63%
Return on Equity (ttm)
18.10%
Revenue (ttm)
274.42M
Net Income Avi to Common (ttm)
28.52M
Diluted EPS (ttm)
1.23
Balance Sheet and Cash Flow
Total Cash (mrq)
61.03M
Total Debt/Equity (mrq)
26.01%
Levered Free Cash Flow (ttm)
11.34M
Research Analysis: TCMD
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: TCMD
TCMD: Rating decreased to a HOLD
TACTILE SYSTEMS TECHNOLOGY I has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice TargetTCMD: Lowering target price to $9.00
TACTILE SYSTEMS TECHNOLOGY I has an Investment Rating of BUY; a target price of $9.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBullishPrice TargetTCMD: Rating increased to a BUY
TACTILE SYSTEMS TECHNOLOGY I has an Investment Rating of BUY; a target price of $10.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingBullishPrice TargetTCMD: Lowering target price to $9.00
TACTILE SYSTEMS TECHNOLOGY I has an Investment Rating of HOLD; a target price of $9.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingNeutralPrice Target